The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist

Ayse Seyhan, Baris AtaDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, McGill University, Montreal, QC, CanadaAbstract: Corifollitropin alfa is a synthetic recombinant follicle-stimulating hormone (rFSH) molecule containing a hybrid beta subunit, which...

Full description

Bibliographic Details
Main Authors:	Seyhan A, Ata B
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-08-01
Series:	International Journal of Women's Health
Online Access:	http://www.dovepress.com/the-role-of-corifollitropin-alfa-in-controlled-ovarian-stimulation-for-a8032

Similar Items

Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients
by: Jiann-Loung Hwang, et al.
Published: (2018-06-01)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
by: Georg Griesinger, et al.
Published: (2016-01-01)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
by: Joaquín Errázuriz, et al.
Published: (2019-03-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
by: Martin Stimpfel, et al.
Published: (2015-01-01)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
by: Raoul Orvieto, et al.
Published: (2020-05-01)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
by: Gayem İnayet Turgay Çelik, et al.
Published: (2015-01-01)

Oxidative stress markers in GnRH agonist and antagonist protocols in IVF
by: Tulić Lidija, et al.
Published: (2017-01-01)

Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.
by: Jin-song Xiao, et al.
Published: (2014-01-01)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
by: Ashraf Alyasin, et al.
Published: (2016-09-01)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)

GnRH antagonist for pituitary supression in IVF: Is it time for a change of practice?
by: Amr Wahba, et al.
Published: (2011-12-01)

Studies on ovarian GnRH-R and GnRH mRNA, and the direct effects of GnRH on ovarian function in the bovine
by: Ramakrishnappa, Nagaraja
Published: (2009)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

GnRH antagonist for pituitary desensitization in IVF: Is it a time for a change of practice?
by: Mohamed A.F.M. Youssef
Published: (2011-12-01)

Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT
by: Raffaella Depalo, et al.
Published: (2018-03-01)

Use of Corifollitropin Alfa for Ovarian Stimulation: A Retrospective Analysis of 804 Women Undergoing IVF/ICSI
by: Nhu H. Giang, et al.
Published: (2019-06-01)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012-04-01)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
by: Samantha Sperduti, et al.
Published: (2019-11-01)

The IVF Outcome Counseling Based on the Model Combining DHEAS and Age in Patients with Low AMH Prior to the First Cycle of GnRH Antagonist Protocol of Ovarian Stimulation
by: Miro Šimun Alebić, et al.
Published: (2013-01-01)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
by: Maryam Eftekhar, et al.
Published: (2013-01-01)

Normal over rezervine sahip infertil hastalarda IVF-ICSI-ET sikluslarında GnRH agonist uzun protokol ile GnRH antagonist protokolün karşılaştırılması
by: Önder BAŞEĞMEZ, et al.
Published: (2017-03-01)

Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
by: Rok Devjak, et al.
Published: (2012-01-01)

Prolonged GnRH suppression period in controlled ovarian hyperstimulation cycles: Impacts on IVF outcomes?
by: Ozlem Gun Eryilmaz, et al.
Published: (2012-01-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
by: Weijie Xing, et al.
Published: (2015-01-01)

Exploring the impact of GnRH agonist and GnRH antagonist on the risk of atopic diseases in patients with prostatic cancer
by: Mei-Yu Lee, et al.
Published: (2018)

Klinische Studien/Klinische Praxis: Expertenkommentar zur Metaanalyse "Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis"
by: Just A
Published: (2015-01-01)

Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates
by: Mohammed M. Laqqan, et al.
Published: (2021-05-01)

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.
by: Ming-Chao Huang, et al.
Published: (2018-01-01)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
by: Hwu Yuh-Ming, et al.
Published: (2009-03-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis.
by: Ruolin Wang, et al.
Published: (2017-01-01)

Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients
by: Selman H, et al.
Published: (2016-10-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
by: Emons Günter, et al.
Published: (2003-10-01)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
by: Harpreet Kaur, et al.
Published: (2012-01-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
by: Abbas Aflatoonian, et al.
Published: (2017-08-01)

A Biological role for GnRH I and GnRH II at the maternal-fetal interface
by: Zhou, Junshan
Published: (2009)